Immunotherapy for malignant glioma

Malignant gliomas (MG) are the most common type of primary malignant brain tumor. Most patients diagnosed with glioblastoma (GBM), the most common and malignant glial tumor, die within 12–15 months. Moreover, conventional treatment, which includes surgery followed by radiation and chemotherapy, can...

Descripción completa

Detalles Bibliográficos
Autores principales: Suryadevara, Carter M., Verla, Terence, Sanchez-Perez, Luis, Reap, Elizabeth A., Choi, Bryan D., Fecci, Peter E., Sampson, John H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Surgical Neurology International: Neuro-Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338494/
https://www.ncbi.nlm.nih.gov/pubmed/25722935
http://dx.doi.org/10.4103/2152-7806.151341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338494/
https://www.ncbi.nlm.nih.gov/pubmed/25722935
http://dx.doi.org/10.4103/2152-7806.151341

Ejemplares similares